Airsonett

Airsonett is a Swedish Medtech company offering an effective treatment for allergic diseases such as asthma and atopic dermatitis. Their patented TLA technology creates a 99.5% clean air zone around the patient’s breathing area during sleep, so the immune system and airways can rest and recuperate.

TLA is the only clinically proven treatment based on allergen avoidance and have been validated in several clinical trials. It is successfully implemented in the Swedish healthcare system with more than 800 current patients.

Industry
HealthTech
Sector
MedTech
Location
Ängelholm
Partnered
2022
Fund
FSG I